icotinib相关论文
Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after f
...
目的探讨消癌平注射液与埃克替尼联合对非小细胞肺癌晚期患者肿瘤局部控制率及血清鳞状细胞癌抗原(SCCA)、基质金属蛋白酶-9(MMP-9......
1例68岁女性患者因肺癌并全身多发骨转移口服盐酸埃克替尼0.125 mg，3次/d。第2天患者出现少量鲜血便，约20 ml，遂自行停药。第3天便血......
1例85岁女性患者因肺癌口服埃克替尼125 mg、3次/d，用药前PLT为216×109/L。用药第7天PLT为107×109/L，第11天为81×109/L，第15天为73......
Phase Ⅰ trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Ch
Background The preclinical experiments and studies of congener drugs show icotinib, a new epidermal growth factor recept......
Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after f
Background The preclinical experiments and several clinical studies showed icotinib,an oral epidermal growth factor rece......
Icotinib, an EGFR-TKI, for the treatment of brain metastases in non-small cell lung cancer：a retrosp
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
目的：观察埃克替尼治疗化疗失败的晚期非小细胞肺癌（NSCLC）患者近期疗效及不良反应。方法25例患者给予埃克替尼125mg口服,3次/d。2个......
目的：研究 MAPK/ ERK 通路及泛素连接酶 c - Cbl 调控埃克替尼抑制 eCC827细胞增殖和诱导细胞凋亡的作用机制。方法：采用 MTT 法检测......
Phase Ⅰ trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Ch
Background The preclinical experiments and studies of congener drugs show icotinib, a new epidermal growth factor recept......
目的探讨慢性粒细胞白血病合并肺腺癌患者靶向药物治疗的药学监护要点。方法对1例服用达沙替尼和埃克替尼的慢性粒细胞白血病合并......
